100Xfounder
Get Featured

Clinical-stage therapeutics company with a computational deep learning peptide design platform Biotech Healthcare

About Peptilogics

The Problem Peptilogics addresses a core startup pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.

The Solution Clinical-stage therapeutics company with a computational deep learning peptide design platform Biotech Healthcare In practice, Peptilogics centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.

Why it's growing With the rise of shifting customer expectations, faster digital adoption, and demand for measurable ROI, Peptilogics is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.

Culture The team operates in a fast-paced environment focused on startup innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.

Why it Matters

Peptilogics matters now because with the rise of shifting customer expectations, faster digital adoption, and demand for measurable ROI, Peptilogics is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.

Funding Snapshot

Total Funding: $35.00MLast Round: Series B Founders Fund, $35M Series B in 2020, $142M valuationAll Rounds: 1
  • Series BFounders Fund, $35M Series B in 2020, $142M valuation

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

AWSReactPythonPostgreSQL

Last updated: February 23, 2026

Peptilogics intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

Related Companies

Alternatives in Startup with comparable market signals.

Discover Now

Newsroom and topic pages connected to Peptilogics.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About Peptilogics

Common questions people ask about this profile.

What is Peptilogics?

Clinical-stage therapeutics company with a computational deep learning peptide design platform Biotech Healthcare

Who founded Peptilogics?

Peptilogics is associated with Peptilogics Team on 100Xfounder.

Where is Peptilogics located?

Peptilogics is listed in Pittsburgh, Pennsylvania, USA.

What stage is Peptilogics in?

Peptilogics is currently mapped to Series B. Funding context: Founders Fund, $35M Series B in 2020, $142M valuation

What is the latest funding round of Peptilogics?

Peptilogics's latest tracked round is Series B Founders Fund, $35M Series B in 2020, $142M valuation. Total tracked rounds: 1.

Is Peptilogics hiring now?

Peptilogics hiring status: Open Roles.

What technologies does Peptilogics use?

Peptilogics is associated with AWS, React, Python, and PostgreSQL.

Is Peptilogics verified on 100Xfounder?

Yes. Peptilogics is currently marked verified on 100Xfounder as of March 3, 2026.

How can users connect with Peptilogics founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.